Beyond Air(XAIR.US)

Last Updated 19:00:00 ET
longbridge loading
Company Encyclopedia
View More
name
Beyond Air
XAIR.US
Beyond Air, Inc., a commercial-stage medical device and biopharmaceutical company, develops the Lungfit platform, a nitric oxide (NO) generator and delivery system platform. It operates through three segments: Beyond Air, Beyond Cancer, and NeuroNos. The company offers Lungfit PH for the treatment of persistent pulmonary hypertension of the newborn. It is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired pneumonia, including COVID-19 and bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria (NTM) at home.
1.298 T
XAIR.USMarket value -Rank by Market Cap -/-

Financial Score

17/02/2026 Update
D
Health Care EquipmentIndustry
Industry Ranking141/184
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreE
    • ROE-240.74%E
    • Profit Margin-447.73%E
    • Gross Margin13.67%D
  • Growth ScoreB
    • Revenue YoY129.04%A
    • Net Profit YoY40.72%B
    • Total Assets YoY7.70%B
    • Net Assets YoY-54.92%E
  • Cash ScoreB
    • Cash Flow Margin-22.33%D
    • OCF YoY129.04%A
  • Operating ScoreD
    • Turnover0.2D
  • Debt ScoreE
    • Gearing Ratio77.47%E

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Analyst Warns: Failure of NeuroNOS Acquisition Could Pressure Beyond Air’s Strategy, Finances, and Stock Price

    Tip Ranks·
    US
    XAIR
    -0.95%
    Tip Ranks·
    US
    XAIR
    -0.95%

    Beyond Air GAAP EPS of -$0.85 misses by $0.03, revenue of $2.2M beats by $0.05M

    businessinsider·
    US
    XAIR
    -0.95%
    businessinsider·
    US
    XAIR
    -0.95%

    Insights into Beyond Air Q3 Earnings

    benzinga_article·
    US
    XAIR
    -0.95%
    benzinga_article·
    US
    XAIR
    -0.95%

    Beyond Air® Reports Fiscal Third Quarter 2026 Financial Results and Provides Corporate Update

    fidelity·
    US
    VHT
    -0.02%
    US
    PBE
    +0.37%
    US
    IBB
    +0.52%
    fidelity·
    US
    VHT
    -0.02%
    US
    PBE
    +0.37%
    US
    IBB
    +0.52%

    Earnings Scheduled For February 13, 2026

    benzinga_article·
    US
    CHH
    -1.64%
    US
    XAIR
    -0.95%
    US
    H
    +1.60%
    benzinga_article·
    US
    CHH
    -1.64%
    US
    XAIR
    -0.95%
    US
    H
    +1.60%
    © 2026 Longbridge｜Disclaimer